Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. KAPRUVIA (difélikéfaline)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

KAPRUVIA (difélikéfaline)

Medicine - Posted on Jan 12 2023
Active substance (DCI)
  • difélikéfaline
history (2)
  • 4/22/22

    KAPRUVIA (difelikefaline)

    Autorisation d’accès précoce octroyée à la spécialité KAPRUVIA (Difelikefaline) dans l’indication « Traitement des formes sé...
    icône flèche
  • 1/4/23

    KAPRUVIA (difélikéfaline) - Prurit associé à une maladie rénale chronique

    Key points Approval of reimbursement of KAPRUVIA (difelikefalin) for the “treatment of moderate to severe pruritus associate...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • V03AX04
Manufacturer
VIFOR FRANCE
Presentation

KAPRUVIA 50 µg/ mL, solution injectable
12 flacons en verre de 1 mL (CIP : 34009 550 896 5 0)

All our publications
    Drug therapy Kidney diseases Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PrceNczk7u3M9R8T